Protara Therapeutics
Yahoo Finance • 20 days ago
Protara Therapeutics GAAP EPS of -$0.37
* Protara Therapeutics press release [https://seekingalpha.com/pr/20430631-protara-therapeutics-announces-fourth-quarter-and-full-year-2025-financial-results-and] (TARA [https://seekingalpha.com/symbol/TARA]): Q4 GAAP EPS of -$0.37. *... Full story
Yahoo Finance • last month
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Favorable safety and tolerability profile with no Grade 3 or greater treatment-related adverse events Company expects to complete enrollment of the BCG-Unresponsive cohort of the ADVANCED-2 trial in 2H 2026 Company to host conference cal... Full story
Yahoo Finance • last month
Protara Therapeutics to Participate in Upcoming Investor Conferences
NEW YORK, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will partic... Full story
Yahoo Finance • 4 months ago
Protara Announces Closing of $75 Million Public Offering
NEW YORK, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the closing of... Full story
Yahoo Finance • 4 months ago
Protara Therapeutics Shares Sink 16% After $75 Mln Public Offering
(RTTNews) - Shares of Protara Therapeutics Inc. (TARA) dropped about 16% in pre-market trading on Friday after the company announced the pricing of its underwritten public offering of about 13.04 million shares of common stock at $5.75 per... Full story
Yahoo Finance • 4 months ago
Protara Therapeutics slumps 12%, raises $75M equity at $5.75 per share
* Protara Therapeutics (TARA [https://seekingalpha.com/symbol/TARA]) priced [https://seekingalpha.com/pr/20330040-protara-announces-pricing-of-75-million-public-offering] its underwritten public offering of ~13.04M shares at a price to t... Full story
Yahoo Finance • 4 months ago
Protara Announces Pricing of $75 Million Public Offering
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the pricing of... Full story
Yahoo Finance • 4 months ago
Protara announces proposed public offering
* Protara Therapeutics (TARA [https://seekingalpha.com/symbol/TARA]) on Thursday said it has commenced an underwritten public offering of $75 million in aggregate of shares of its common stock or, in lieu of issuing common stock to certa... Full story
Yahoo Finance • 4 months ago
Protara Announces Proposed Public Offering
NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that it has co... Full story
Yahoo Finance • 4 months ago
Protara down after mid-stage trial data for lead asset
[Anatomy of Lymph Nodes and Lymph Flow] Jitendra Jadhav/iStock via Getty Images Protara Therapeutics (TARA [https://seekingalpha.com/symbol/TARA]) slipped ~6% in the premarket on Wednesday after posting interim data from a mid-stage trial... Full story
Yahoo Finance • 4 months ago
Protara Therapeutics to Host Conference Call and Webcast to Review New Interim Data from Phase 2 STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations on Wednesday, November 19, 2025
NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference... Full story
Yahoo Finance • 5 months ago
Protara Therapeutics GAAP EPS of -$0.31 beats by $0.07
* Protara Therapeutics press release [https://seekingalpha.com/pr/20300363-protara-therapeutics-announces-third-quarter-2025-financial-results-and-provides-business] (TARA [https://seekingalpha.com/symbol/TARA]): Q3 GAAP EPS of -$0.31 be... Full story
Yahoo Finance • 6 months ago
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA) (“Protara” or the “Company”), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announc... Full story
Yahoo Finance • 6 months ago
Analysts Predict Up to 840% Jump for These 2 ‘Strong Buy’ Penny Stocks
The stock market’s largest players – companies like Nvidia and its trillion-dollar peers – often dominate the headlines and attract most of the capital. Yet, some of the most compelling opportunities can be found at the smaller end of the... Full story
Yahoo Finance • 8 months ago
Protara Therapeutics GAAP EPS of -$0.35 beats by $0.02
* Protara Therapeutics press release [https://seekingalpha.com/pr/20195899-protara-therapeutics-announces-second-quarter-2025-financial-results-and-provides-business] (NASDAQ:TARA [https://seekingalpha.com/symbol/TARA]): Q2 GAAP EPS of -... Full story
Yahoo Finance • 9 months ago
Protara Therapeutics added to the Russell 3000 index
* Protara Therapeutics (NASDAQ:TARA [https://seekingalpha.com/symbol/TARA]) has been added as a member of the broad-market Russell 3000 Index as part of the annual reconstitution, effective at the open of U.S. equity markets on Monday.... Full story
Yahoo Finance • 9 months ago
Protara Therapeutics Announces Addition to the Russell 3000® Index
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that the Company has been a... Full story
Yahoo Finance • 10 months ago
Protara Therapeutics Announces Appointment of William Conkling as Chief Commercial Officer
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of William... Full story
Yahoo Finance • 11 months ago
Protara Therapeutics to Host Conference Call and Webcast to Review Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC on Monday, April 28, 2025
NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference... Full story
Yahoo Finance • 11 months ago
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced the appointment of Leonard... Full story
